Idexx Laboratories (IDXX) Operating Margin (2009 - 2026)
Idexx Laboratories (IDXX) operating margin from Jun 30, 2009 to Mar 31, 2026. The current Idexx Laboratories (IDXX) operating margin is 31.78%. You can export chart.
All data is split-adjusted. You can find the most accurate data from the reports on the SEC official website. We recommend verify information using official company filings before making investment decisions.
Annual Operating Margin
Quarterly Operating Margin
Annual Operating Margin change of Idexx Laboratories (IDXX)
| Year | Operating Margin | Change |
|---|---|---|
| 2025 | 31.60% | +9.16% |
| 2024 | 28.95% | -3.40% |
| 2023 | 29.97% | +12.28% |
| 2022 | 26.69% | -7.92% |
| 2021 | 28.99% | +12.97% |
| 2020 | 25.66% | +11.71% |
| 2019 | 22.97% | +3.47% |
| 2018 | 22.20% | +3.19% |
| 2018 | 21.51% | -14.18% |
| 2018 | 25.07% | +19.24% |
| 2018 | 21.02% | +0.23% |
| 2017 | 20.98% | +2.78% |
| 2017 | 20.41% | -15.25% |
| 2017 | 24.08% | +20.62% |
| 2017 | 19.96% | +1.20% |
| 2016 | 19.73% | -0.02% |
| 2016 | 19.73% | -11.61% |
| 2016 | 22.32% | +26.33% |
| 2016 | 17.67% | -5.61% |
| 2015 | 18.72% | +5.82% |
| 2015 | 17.69% | -17.18% |
| 2015 | 21.36% | +12.24% |
| 2015 | 19.03% | +8.66% |
| 2014 | 17.52% | -6.94% |
| 2014 | 18.82% | -11.76% |
| 2014 | 21.33% | +9.69% |
| 2014 | 19.45% | +0.39% |
| 2013 | 19.37% | +0.07% |
| 2013 | 19.36% | -13.34% |
| 2013 | 22.34% | +21.24% |
| 2013 | 18.42% | -9.24% |
| 2012 | 20.30% | +1.80% |
| 2012 | 19.94% | -11.72% |
| 2012 | 22.59% | +20.66% |
| 2012 | 18.72% | -3.42% |
| 2011 | 19.38% | +3.99% |
| 2011 | 18.64% | -16.90% |
| 2011 | 22.43% | +22.64% |
| 2011 | 18.29% | -1.01% |
| 2010 | 18.48% | +0.02% |
| 2010 | 18.47% | -5.18% |
| 2010 | 19.48% | +8.02% |
| 2010 | 18.04% | +5.74% |
| 2009 | 17.06% | +1.28% |
| 2008 | 16.84% | N/A |
Comparison Idexx Laboratories (IDXX) operating margin with competitors
Idexx Laboratories (IDXX) operating margin is 31.78%.
| Ticker | Name | Operating Margin | Upside |
|---|---|---|---|
| SHC | Sotera Health Company | 28.16% | -11.40% |
| MTD | Mettler-Toledo International Inc | 26.00% | -18.20% |
| DHR | Danaher Corp | 22.58% | -28.96% |
| QGEN | Qiagen NV | 22.29% | -29.87% |
| MEDP | Medpace Holdings Inc | 20.03% | -36.98% |
| A | Agilent Technologies Inc | 19.63% | -38.24% |
| ILMN | Illumina Inc | 19.16% | -39.72% |
| TMO | Thermo Fisher Scientific Inc | 16.93% | -46.73% |
| BLLN | Billiontoone Inc - Class A | 16.45% | -48.24% |
| VCYT | Veracyte Inc | 16.28% | -48.78% |
| DGX | Quest Diagnostics Inc | 13.78% | -56.64% |
| IQV | IQVIA Holdings Inc | 12.38% | -61.05% |
| CRL | Charles River Laboratories International Inc | 12.04% | -62.12% |
| LH | Laboratory Corp Of America Holdings | 10.76% | -66.15% |
| RVTY | Revvity Inc | 10.67% | -66.43% |
| CDNA | Caredx Inc | 1.02% | -96.79% |